Research Progress on Classical Traditional Chinese Medicine Formula Xiaoyaosan in the Treatment of Depression

Overview

Journal Front Pharmacol

Date 2022 Aug 22

PMID 35991880

Authors

Jianbei Chen

Chaofang Lei

Xiaojuan Li

Qian Wu

Chenyue Liu

Qingyu Ma

Jiaxu Chen

Affiliations

Soon will be listed here.

Abstract

Depression is an emotional disorder that is problematic in psychiatry owing to its unclear etiology and unknown pathogenesis. Traditional Chinese medicine formulations such as Xiaoyaosan have been widely used throughout history to treat depression. In this review, we have focused on recent evidences elucidating the links between Xiaoyaosan and the treatment of depression. Data from animal and clinical studies, focusing on the pharmacological mechanisms, clinical applications, and effective materials that form the basis for the treatment of depression are presented and discussed. We found that the antidepressant effects of Xiaoyaosan are related to the effects of monoamine neurotransmitters, regulation of the hypothalamic-pituitary-adrenal axis, neuroplasticity, synaptic plasticity, inflammatory response, neuroprotection, brain-gut axis, regulation of intestinal microbiota, oxidative stress, and autophagy for reducing neuronal apoptosis. This review highlights the current evidence supporting the use of Xiaoyaosan as an antidepressant and provides an overview of the potential mechanisms involved.

Citing Articles

Efficacy and safety of Xiaoyao San in the treatment of chronic fatigue syndrome: a systematic review and meta-analysis.

Wang Q, Zhou J, Gong G Front Pharmacol. 2025; 16:1496774.

PMID: 39981187 PMC: 11839657. DOI: 10.3389/fphar.2025.1496774.

Integrated colon microbiome and metabolomics to elucidate the antidepressant mechanisms of the Radix Bupleuri-Radix Paeoniae Alba herb pair.

Lv J, Bai Y, Lv Y, Chen C, Qin X, Du G Metab Brain Dis. 2024; 40(1):45.

PMID: 39607539 DOI: 10.1007/s11011-024-01450-4.

Effect of Xiaoyaosan on brain volume and microstructure diffusion changes to exert antidepressant-like effects in mice with chronic social defeat stress.

Li Y Front Psychiatry. 2024; 15:1414295.

PMID: 39371910 PMC: 11450227. DOI: 10.3389/fpsyt.2024.1414295.

Effectiveness and safety of Arecae Semen compounds for patients with depression: a systematic review and meta-analysis.

Lin T, Zang X, Chen Y, Zhao L, Zhang Y Syst Rev. 2024; 13(1):238.

PMID: 39300549 PMC: 11411766. DOI: 10.1186/s13643-024-02656-4.

The therapeutic potential of traditional Chinese medicine in depression: focused on the modulation of neuroplasticity.

Lv S, Yang N, Lu Y, Zhang G, Zhong X, Cui Y Front Pharmacol. 2024; 15:1426769.

PMID: 39253375 PMC: 11381291. DOI: 10.3389/fphar.2024.1426769.

References

Kou M, Chen J . Integrated traditional and Western medicine for treatment of depression based on syndrome differentiation: a meta-analysis of randomized controlled trials based on the Hamilton depression scale. J Tradit Chin Med. 2012; 32(1):1-5. DOI: 10.1016/s0254-6272(12)60023-5. View

Du H, Ming L, Chen S, Li C . Xiaoyao pill for treatment of functional dyspepsia in perimenopausal women with depression. World J Gastroenterol. 2014; 20(44):16739-44. PMC: 4248221. DOI: 10.3748/wjg.v20.i44.16739. View

Papandreou V, Magiatis P, Kalpoutzakis E, Skaltsounis A, Harvala C . Paeonicluside, a new salicylic glycoside from the Greek endemic species Paeonia clusii. Z Naturforsch C J Biosci. 2002; 57(3-4):235-8. DOI: 10.1515/znc-2002-3-406. View

Carpenter L, Moreno F, Kling M, Anderson G, Regenold W, Labiner D . Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients. Biol Psychiatry. 2004; 56(6):418-26. DOI: 10.1016/j.biopsych.2004.06.025. View

Zhang N, Liu C, Sun T, Ran X, Kang T, Dou D . Two new compounds from Atractylodes macrocephala with neuroprotective activity. J Asian Nat Prod Res. 2016; 19(1):35-41. DOI: 10.1080/10286020.2016.1247351. View

Hao W, Wu J, Yuan N, Gong L, Huang J, Ma Q . Xiaoyaosan Improves Antibiotic-Induced Depressive-Like and Anxiety-Like Behavior in Mice Through Modulating the Gut Microbiota and Regulating the NLRP3 Inflammasome in the Colon. Front Pharmacol. 2021; 12:619103. PMC: 8087337. DOI: 10.3389/fphar.2021.619103. View

Zhou X, Liu C, Liu Y, Ma Q, Zhao X, Jiang Y . Xiaoyaosan Alleviates Hippocampal Glutamate-Induced Toxicity in the CUMS Rats via NR2B and PI3K/Akt Signaling Pathway. Front Pharmacol. 2021; 12:586788. PMC: 8075411. DOI: 10.3389/fphar.2021.586788. View

Wang J, Li X, He S, Hu L, Guo J, Huang X . Regulation of the kynurenine metabolism pathway by Xiaoyao San and the underlying effect in the hippocampus of the depressed rat. J Ethnopharmacol. 2017; 214:13-21. DOI: 10.1016/j.jep.2017.11.037. View

Gao L, Huang P, Dong Z, Gao T, Huang S, Zhou C . Modified Xiaoyaosan (MXYS) Exerts Anti-depressive Effects by Rectifying the Brain Blood Oxygen Level-Dependent fMRI Signals and Improving Hippocampal Neurogenesis in Mice. Front Pharmacol. 2018; 9:1098. PMC: 6173122. DOI: 10.3389/fphar.2018.01098. View

10.

. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015; 386(9995):743-800. PMC: 4561509. DOI: 10.1016/S0140-6736(15)60692-4. View

11.

Wang C, Wu C, Yan Z, Cheng X . Ameliorative effect of Xiaoyao-jieyu-san on post-stroke depression and its potential mechanisms. J Nat Med. 2018; 73(1):76-84. DOI: 10.1007/s11418-018-1243-5. View

12.

Zhang S, Liu X, Sun M, Zhang Q, Li T, Li X . Reversal of reserpine-induced depression and cognitive disorder in zebrafish by sertraline and Traditional Chinese Medicine (TCM). Behav Brain Funct. 2018; 14(1):13. PMC: 6001006. DOI: 10.1186/s12993-018-0145-8. View

13.

Gilman S, Iossifov I, Levy D, Ronemus M, Wigler M, Vitkup D . Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses. Neuron. 2011; 70(5):898-907. PMC: 3607702. DOI: 10.1016/j.neuron.2011.05.021. View

14.

Liu Y, Ding X, Wang X, Zou X, Li X, Liu Y . Xiaoyaosan exerts antidepressant-like effects by regulating the functions of astrocytes and EAATs in the prefrontal cortex of mice. BMC Complement Altern Med. 2019; 19(1):215. PMC: 6694586. DOI: 10.1186/s12906-019-2613-6. View

15.

Liu X, Liu C, Tian J, Gao X, Li K, Du G . Plasma metabolomics of depressed patients and treatment with Xiaoyaosan based on mass spectrometry technique. J Ethnopharmacol. 2019; 246:112219. DOI: 10.1016/j.jep.2019.112219. View

16.

Machaalani R, Chen H . Brain derived neurotrophic factor (BDNF), its tyrosine kinase receptor B (TrkB) and nicotine. Neurotoxicology. 2018; 65:186-195. DOI: 10.1016/j.neuro.2018.02.014. View

17.

Xu Y, Ku B, Cui L, Li X, Barish P, Foster T . Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats. Brain Res. 2007; 1162:9-18. DOI: 10.1016/j.brainres.2007.05.071. View

18.

Meng Z, Hu J, Chen J, Yue G . Xiaoyaosan decoction, a traditional chinese medicine, inhibits oxidative-stress-induced hippocampus neuron apoptosis in vitro. Evid Based Complement Alternat Med. 2012; 2012:489254. PMC: 3273328. DOI: 10.1155/2012/489254. View

19.

Tian J, Peng G, Wu Y, Zhou J, Xiang H, Gao X . A GC-MS urinary quantitative metabolomics analysis in depressed patients treated with TCM formula of Xiaoyaosan. J Chromatogr B Analyt Technol Biomed Life Sci. 2016; 1026:227-235. DOI: 10.1016/j.jchromb.2015.12.026. View

20.

Olloquequi J, Cornejo-Cordova E, Verdaguer E, Soriano F, Binvignat O, Auladell C . Excitotoxicity in the pathogenesis of neurological and psychiatric disorders: Therapeutic implications. J Psychopharmacol. 2018; 32(3):265-275. DOI: 10.1177/0269881118754680. View